Physician profile
David S Fieno
NPI 1518189182
$420,561.41
in general payments reported to CMS, 2019-2025
44 companies · $108K in 2025
The $108K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,495 · 2020: $15K · 2021: $25K · 2022: $57K · 2023: $90K · 2024: $124K · 2025: $108K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250K · Travel and Lodging: $42K · Consulting Fee: $17K · Food and Beverage: $10K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,050 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250,011.69 |
| Travel and Lodging | $41,654.35 |
| Consulting Fee | $16,909.00 |
| Food and Beverage | $10,406.05 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,050.00 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $153,467.33 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $101,586.75 | 2022-2025 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $22,537.50 | 2020-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21,161.28 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20,790.82 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $19,814.70 | 2020-2023 | Xarelto |
| Lilly USA, LLC | $18,364.91 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Boston Scientific Corporation | $11,722.99 | 2019-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Philips North America LLC | $10,040.91 | 2019-2025 | (9520) Igt Devices Undivided, (9520) Igt Devices Und, Igt Devices Undivided |
| Merit Medical Systems INC | $9,813.00 | 2025 | Flextract |
| Abbott Laboratories | $8,740.79 | 2019-2025 | Cardiomems, Mitraclip, Aveir |
| Esperion Therapeutics, INC. | $7,038.17 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $5,173.50 | 2021-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $2,228.25 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Venaseal |
| Biotronik INC. | $1,171.68 | 2020-2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $838.02 | 2021-2024 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $819.75 | 2022-2023 | Biograph Horizon-3r |
| Elutia, INC. | $787.34 | 2019-2025 | Ecm Patch,Pouch |
| Bard Peripheral Vascular, INC. | $700.81 | 2022-2025 | Venclose Maven Catheter |
| Medtronic Vascular, INC. | $618.62 | 2019-2020 | |
| Amgen INC. | $413.23 | 2019-2023 | Repatha |
| Janssen Scientific Affairs, LLC | $383.37 | 2019-2023 | Xarelto |
| Pfizer INC. | $368.22 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $299.75 | 2021-2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $279.92 | 2019-2025 | |
| Cook Medical LLC | $240.33 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $207.06 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $175.73 | 2024 | |
| Medicomp INC | $159.95 | 2023 | Telepatch Cardiac Monitor |
| Akcea Therapeutics, INC. | $131.98 | 2019 | |
| Bridgebio Pharma, INC. | $119.36 | 2025 | Attruby |
| Sanofi-Aventis U.S. LLC | $57.76 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.89 | 2025 | |
| Genzyme Corporation | $53.88 | 2020-2025 | |
| Inari Medical, INC. | $40.43 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $35.50 | 2022 | |
| Acutus Medical, INC. | $21.87 | 2020 | |
| Sobi, INC | $20.01 | 2021 | |
| Tactile Systems Technology INC | $17.19 | 2023 | Flexitouch Plus, Entre Plus |
| Chiesi USA, INC. | $17.11 | 2025 | Kengreal |
| Angiodynamics, INC. | $15.43 | 2023 | Auryon Laser System 100-120 Vac |
| Currax Pharmaceuticals LLC | $11.67 | 2020 | |
| Amarin Pharma, INC. | $10.97 | 2019 | |
| Lemaitre Vascular, INC. | $8.68 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fieno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.